Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma

Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma Cancer Causes Control (2017) 28:971–979 DOI 10.1007/s10552-017-0929-4 BRIEF REPORT Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma 1,2 1 1 3 • • • Ellen T. Chang Edmund C. Lau Fionna S. Mowat M. Jane Teta Received: 12 January 2017 / Accepted: 20 July 2017 / Published online: 28 July 2017 Springer International Publishing AG 2017 Abstract Conclusions The increase in second primary mesothelioma Purpose This large, population-based U.S. study of lym- risk following radiotherapy for lymphoma is independent phoma patients followed for up to four decades enables of several patient and disease characteristics, and is higher detailed analysis of second primary mesothelioma risk after with earlier treatment era and longer latency. radiotherapy. Methods U.S. Surveillance, Epidemiology, and End Keywords Hodgkin lymphoma  Non-Hodgkin Results data were used to identify second primary lymphoma  Mesothelioma  Radiotherapy  Epidemiology mesothelioma among patients diagnosed with Hodgkin SEER Program lymphoma (HL) or non-Hodgkin lymphoma (NHL) between 1973 and 2014. Standardized incidence ratios (SIRs) were calculated by radiotherapy. Multivariate Introduction adjusted associations were examined using competing risks survival analysis. Ionizing radiation, a known human carcinogen, has been Results Among 47,219 HL patients (19,538 irradiated) and used since the 1950s http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Cancer Causes & Control Springer Journals

Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma

Loading next page...
 
/lp/springer_journal/therapeutic-radiation-for-lymphoma-and-risk-of-second-primary-5DN20orD8k
Publisher
Springer International Publishing
Copyright
Copyright © 2017 by Springer International Publishing AG
Subject
Biomedicine; Cancer Research; Biomedicine, general; Oncology; Public Health; Epidemiology; Hematology
ISSN
0957-5243
eISSN
1573-7225
D.O.I.
10.1007/s10552-017-0929-4
Publisher site
See Article on Publisher Site

Abstract

Cancer Causes Control (2017) 28:971–979 DOI 10.1007/s10552-017-0929-4 BRIEF REPORT Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma 1,2 1 1 3 • • • Ellen T. Chang Edmund C. Lau Fionna S. Mowat M. Jane Teta Received: 12 January 2017 / Accepted: 20 July 2017 / Published online: 28 July 2017 Springer International Publishing AG 2017 Abstract Conclusions The increase in second primary mesothelioma Purpose This large, population-based U.S. study of lym- risk following radiotherapy for lymphoma is independent phoma patients followed for up to four decades enables of several patient and disease characteristics, and is higher detailed analysis of second primary mesothelioma risk after with earlier treatment era and longer latency. radiotherapy. Methods U.S. Surveillance, Epidemiology, and End Keywords Hodgkin lymphoma  Non-Hodgkin Results data were used to identify second primary lymphoma  Mesothelioma  Radiotherapy  Epidemiology mesothelioma among patients diagnosed with Hodgkin SEER Program lymphoma (HL) or non-Hodgkin lymphoma (NHL) between 1973 and 2014. Standardized incidence ratios (SIRs) were calculated by radiotherapy. Multivariate Introduction adjusted associations were examined using competing risks survival analysis. Ionizing radiation, a known human carcinogen, has been Results Among 47,219 HL patients (19,538 irradiated) and used since the 1950s

Journal

Cancer Causes & ControlSpringer Journals

Published: Jul 28, 2017

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Search

Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly

Organize

Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.

Access

Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

DeepDyve

Freelancer

DeepDyve

Pro

Price

FREE

$49/month
$360/year

Save searches from
Google Scholar,
PubMed

Create lists to
organize your research

Export lists, citations

Read DeepDyve articles

Abstract access only

Unlimited access to over
18 million full-text articles

Print

20 pages / month

PDF Discount

20% off